Today: 17 May 2026
SoFi stock ends week on a sharp drop — what traders are watching next
1 March 2026
1 min read

SoFi stock ends week on a sharp drop — what traders are watching next

New York, March 1, 2026, 14:37 EST — Market finished the session

  • SoFi saw its shares tumble 7.0% Friday, with trading volume running unusually high.
  • Financials and tech shares got caught up in a wider risk-off mood, and the move followed that pattern.
  • Attention now swings to U.S. jobs numbers due March 6, with the Fed’s March 17-18 meeting also looming.

SoFi Technologies, Inc. dropped 7.0% on Friday, ending the session at $17.76. The stock hit a low of $17.31 during the day as sellers stepped in late week. Trading volume swelled to around 115.3 million shares—well above Thursday’s 69.9 million.

The drop stings going into Monday. SoFi acts like a high-beta lender—it takes the brunt when risk appetite fades or interest rate outlooks sour. After Friday’s slide, momentum is against the stock heading into the new week.

Friday brought a quick change in tone on Wall Street. Financials and tech stocks slid after a stronger inflation print, fresh anxiety over AI-related disruptions, renewed tariff questions, and heightened geopolitical strains, according to Reuters. “We were reminded there are still some cracks out there,” said Ryan Detrick, chief market strategist at Carson Group, in the story. Reuters

No clear SoFi headline cropped up during the session to justify the drop. Instead, traders talked about what was on the screens: big volume, jittery sentiment, and a market-wide selloff that hit rate-sensitive stocks across the board.

Digital lenders are feeling the heat. Margins get pinched as funding costs rise, and stricter credit slows down loan growth. SoFi’s stock, for its part, tends to move on the back of macro numbers and what the Fed might do—even when the company’s own outlook hasn’t shifted.

This week, two key dates could shake up forecasts. First up: the U.S. employment report for February hits at 8:30 a.m. ET on March 6—a release known for jolting Treasury yields and shifting bets on rate cuts.

Next up: the Federal Reserve’s policy gathering on March 17-18. Investors will be scanning the statement for tweaks to how officials talk about inflation and interest rates.

SoFi bulls face a real risk: if Friday’s selloff deepens thanks to another inflation surprise or continued focus on strict lending standards, investors could keep cutting back on growth-focused financials.

What’s next? Friday’s jobs numbers, followed by the Fed’s meeting in two weeks, are the obvious macro triggers on the horizon.

Stock Market Today

  • Morningstar outlines 3 reasons for potential surge in bond yields
    May 16, 2026, 10:03 PM EDT. Morningstar identifies three key factors that could drive bond yields higher in the near term. Rising inflation expectations, central banks' tightening policies, and increased government borrowing are contributing to upward pressure on yields, which represent the return on government and corporate debt. Higher bond yields can increase borrowing costs and impact stock valuations, by making fixed-income investments more attractive relative to equities. Investors should monitor these indicators closely as bond market dynamics shift amid evolving economic conditions.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
GE Aerospace stock price near record high as supply-chain bottlenecks stay in focus
Previous Story

GE Aerospace stock price near record high as supply-chain bottlenecks stay in focus

Qantas share price slides on Iran conflict and oil spike — what investors watch next
Next Story

Qantas share price slides on Iran conflict and oil spike — what investors watch next

Go toTop